Altamira Therapeutics Ltd.
CYTO
Revenue
305.62k
▲241.73k▲378.41%
12 Months ChangeAssets
7.69M
▲1.49M▲24.02%
6 Months ChangeLiabilities
1.24M
▼-6.79M▼-84.61%
6 Months ChangeFree Cash Flow
-13.23M
▲11.05M▲45.51%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-04-10
Form 20-F
ID: 0001213900-24-031734
2023-05-16
Form 20-F
ID: 0001213900-23-040152
2022-04-12
Form 20-F
ID: 0001213900-22-019292
2021-03-31
Form 20-F
ID: 0001213900-21-018959
2020-04-16
Form 20-F
ID: 0001213900-20-009292
2019-03-14
Form 20-F
ID: 0001601936-19-000008
2018-03-22
Form 20-F
ID: 0001601936-18-000007
2017-03-14
Form 20-F
ID: 0000950103-17-002421
2016-03-14
Form 20-F
ID: 0000950103-16-011830
2015-03-31
Form 20-F
ID: 0000950103-15-002491